Page last updated: 2024-10-26

erythrosine and Breast Neoplasms

erythrosine has been researched along with Breast Neoplasms in 100 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
" In this work, an endogenous ligand, estrone, was used to synthesize doxorubicin-encapsulating liposomes for estrogen receptor (ER)-positive breast cancer therapy with cyanuric chloride (2,4,6 trichloro-1,3,5 triazine) being used as a linking molecule to attach 3-OH group of estrone to the surface of liposomes."7.88Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy. ( Al Sayah, M; Husseini, GA; Kawak, P; Martins, AM; Paul, V; Salkho, NM; Vitor, RF, 2018)
" In this work, an endogenous ligand, estrone, was used to synthesize doxorubicin-encapsulating liposomes for estrogen receptor (ER)-positive breast cancer therapy with cyanuric chloride (2,4,6 trichloro-1,3,5 triazine) being used as a linking molecule to attach 3-OH group of estrone to the surface of liposomes."3.88Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy. ( Al Sayah, M; Husseini, GA; Kawak, P; Martins, AM; Paul, V; Salkho, NM; Vitor, RF, 2018)
"Fluorescein-labeled dextrans (FITC-D) from 3 to 5000 kDa (Stokes' radii from 1 to 40 nm) were used to study influx from the plasma into the peritoneum and efflux from the peritoneal cavity into the plasma in normal and ascites tumor-bearing mice and in mice whose peritoneal vessels had been rendered hyperpermeable by serotonin."3.67Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. ( Dvorak, HF; Herzberg, KT; Masse, EM; Nagy, JA; Zientara, GP, 1989)
"Breast cancer specimens from 184 patients were analyzed for estrogen binding by two different histochemical techniques using conjugates of estradiol, bovine serum albumin, and fluorescein."3.67Heterogeneity of estrogen binding sites in breast cancer: morphologic demonstration and relationship to endocrine response. ( Carter, AC; Eisenberg, KB; Feldman, JG; Pertschuk, LP, 1985)
"Breast cancer is a devastating disease, with different types of breast cancer recurring locally or distant as metastatic/advanced disease following initial treatment."1.51A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer. ( Brutkiewicz, RR; Liu, J; Seki, T; Tsuji, M, 2019)
"Breast and cervical cancer cells that stably expressed apoptotic sensor proteins were used to determine apoptosis in real-time by fluorescence resonance energy transfer (FRET)-based imaging microscopy."1.48Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells. ( Fung, TS; Lim, S; Luo, KQ; Regmi, S, 2018)
"In vitro studies with MDA-MB-231-LM2 breast cancer cell line showed significant cell killing upon treatment of cell-liposome suspensions with the laser."1.42Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts. ( Blumenthal, R; Charron, H; Joshi, A; Puri, A; Schiff, R; Sine, J; Tata, DB; Thayer, D; Urban, C; Valim, N, 2015)
"In Akt-hyperactive cancer, TopBP1 forms oligomers and represses E2F1-dependent apoptosis."1.40Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy. ( Chowdhury, P; Lin, FT; Lin, GE; Lin, WC; Liu, K; Song, Y, 2014)
"Breast cancer is the leading cause of cancer deaths among non-smoking women worldwide."1.35Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs. ( Andersson, H; Franke, HR; Komen, J; van den Berg, A; Vermes, I; Wolbers, F, 2008)
"One of the major clinical problems in breast cancer detection is the relatively high incidence of occult lymph node metastases undetectable by standard procedures."1.35Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes. ( Afrimzon, E; Deutsch, A; Deutsch, M; Pappo, I; Sandbank, J; Shafran, Y; Zurgil, N, 2008)
"Efflux transporters, p-glycoprotein and breast cancer resistance protein (BCRP), located at barrier sites such as the blood-brain barrier may affect distribution of steroids used for treating chronic inflammatory conditions and thus the extent to which they may perturb the hypothalamic-pituitary-adrenal axis."1.33Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids. ( Barrand, MA; Cahn, AP; Cooray, HC; Hladky, SB; Shahi, S; van Veen, HW, 2006)
"Screening on MDA-MB-435 breast carcinoma xenografts yielded multiple copies of a phage that displays a cyclic 9-amino-acid peptide, LyP-1."1.31A tumor-homing peptide with a targeting specificity related to lymphatic vessels. ( Hoffman, JA; Laakkonen, P; Porkka, K; Ruoslahti, E, 2002)
"Sixty-nine patients with invasive breast cancer underwent subcutaneous mastectomy and immediate reconstruction with a subcutaneously placed prosthesis."1.29Influence of the site of skin incision on the circulation in the nipple-areola complex after subcutaneous mastectomy in breast cancer. ( Perbeck, LG; Proano, E, 1996)
"Neoplastic cells of both mammary and extramammary Paget's disease showed cytoplasmic staining with both lectins."1.27Lectin-binding sites in Paget's disease. ( Furue, M; Hino, H; Ohara, K; Tamaki, K, 1985)
"Cell surface glycoconjugates of human breast cancer tissue were investigated using FITC peanut (PNA), wheat germ (WGA) and jackbean (concanavalin A; Con A) agglutinins."1.27Lectin binding in human breast cancer: clinical and pathologic correlations with fluorescein-conjugated peanut, wheat germ and concanavalin A binding. ( Bezwoda, WR; Dansey, R; Murray, J; Ninin, D, 1988)
" FCM quantification of E-BSA-FITC binding intensity demonstrates a saturable dose-response that is specifically reduced in the presence of diethylstilbestrol (DES) in doses known to saturate Type I ER."1.27Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in breast cancer suspensions. ( Benz, C; Lee, SH; Wiznitzer, I, 1985)

Research

Studies (100)

TimeframeStudies, this research(%)All Research%
pre-199039 (39.00)18.7374
1990's16 (16.00)18.2507
2000's19 (19.00)29.6817
2010's21 (21.00)24.3611
2020's5 (5.00)2.80

Authors

AuthorsStudies
Mukundan, S1
Bell, J1
Teryek, M1
Hernandez, C1
Love, AC1
Parekkadan, B1
Chan, LL1
Melling, GE1
Conlon, R1
Pantazi, P1
Dellar, ER1
Samuel, P1
Baena-Lopez, LA1
Simpson, JC1
Carter, DRF1
Hübner, C1
Keil, C1
Jürgensen, A1
Barthel, L1
Haase, H1
Zhou, X1
Ding, G1
Fang, Q1
Guo, J1
Yang, L2
Wang, P1
Fu, SZ1
Li, A1
Xia, J2
Yu, J1
Ma, M1
Hu, Z1
Huang, L1
Liu, R1
Jiang, C1
Li, S1
Yu, M1
Xu, X1
Zhao, Y1
Hu, Q1
Xing, W1
Zhao, Z1
Fawzy, MS1
Ashour, H1
Shafie, AAA1
Dahman, NBH1
Fares, AM1
Antar, S1
Elnoby, AS1
Fouad, FM1
Devine, LD1
Gallagher, AM1
Briggs, S1
Hill, AJ1
Stopyra, W1
Alacamli, G1
Kaderli, ST1
Edebali, S1
Alacamli, OG1
Sul, S1
Canbek, TD1
Karalezli, A1
Stoicescu, EA1
Cherecheanu, AP1
Bostan, M1
Pîrvulescu, R1
Tiu, C1
Bujor, I1
Popa-Cherecheanu, A1
Balogun, MM1
Fashola, MB1
Shi, X1
Yu, X1
Duan, X1
Vandestienne, M1
Braik, R1
Lavillegrand, JR1
Hariri, G1
Demailly, Z1
Ben Hamouda, N1
Tamion, F1
Clavier, T1
Ait-Oufella, H1
Bampidis, V1
Azimonti, G1
Bastos, ML1
Christensen, H1
Durjava, M1
Kouba, M1
López-Alonso, M1
López Puente, S1
Marcon, F1
Mayo, B1
Pechová, A1
Petkova, M1
Ramos, F1
Sanz, Y1
Villa, RE1
Woutersen, R1
Brantom, P1
Chesson, A1
Westendorf, J1
Manini, P1
Dusemund, B1
Bickel Haase, T1
Naumann-Gola, S1
Ortner, E1
Zorn, H1
Schweiggert-Weisz, U1
Yang, N1
Gao, J1
Han, Y1
Zhang, L1
Furusawa, S1
Ikeda, M1
Ide, T1
Kanamura, T1
Miyamoto, HD1
Abe, K1
Ishimaru, K1
Watanabe, M1
Tsutsui, Y1
Miyake, R1
Fujita, S1
Tohyama, T1
Matsushima, S1
Baba, Y1
Tsutsui, H1
Dani, S1
Kumar, R1
Sharma, H1
Choudhary, RJ1
Goyal, N1
Kaur, P1
Pandit, R1
Pang, Y1
Bjornsson, R1
Chung, HR1
Miller, JE1
Suh, JD1
Margolis, G1
Hamuda, N1
Kobo, O1
Elbaz Greener, G1
Amir, O1
Homoud, M1
Madias, C1
Heist, EK1
Ruskin, JN1
Kazatsker, M1
Roguin, A1
Leshem, E1
Rozen, G1
Elamir, A1
Ajith, S1
Sawaftah, NA1
Abuwatfa, W1
Mukhopadhyay, D2
Paul, V3
Al-Sayah, MH2
Awad, N1
Husseini, GA3
Salkho, NM1
Kawak, P1
Vitor, RF1
Martins, AM1
Al Sayah, M1
Klein, S1
Kızaloğlu, M1
Portilla, L1
Park, H1
Rejek, T1
Hümmer, J1
Meyer, K1
Hock, R1
Distel, LVR1
Halik, M1
Kryschi, C1
Regmi, S1
Fung, TS1
Lim, S1
Luo, KQ1
Seki, T1
Liu, J1
Brutkiewicz, RR1
Tsuji, M1
Awad, NS1
Rengan, AK1
Jagtap, M1
De, A1
Banerjee, R1
Srivastava, R1
Zhang, P1
Lock, LL1
Cheetham, AG1
Cui, H1
Chowdhury, P1
Lin, GE1
Liu, K1
Song, Y1
Lin, FT1
Lin, WC1
Maeda, A1
Bu, J1
Chen, J1
Zheng, G1
DaCosta, RS1
Sine, J1
Urban, C1
Thayer, D1
Charron, H1
Valim, N1
Tata, DB1
Schiff, R1
Blumenthal, R1
Joshi, A1
Puri, A1
Abbasi, AZ1
Prasad, P1
Cai, P1
He, C1
Foltz, WD1
Amini, MA1
Gordijo, CR1
Rauth, AM1
Wu, XY1
Khosroshahi, ME1
Hassannejad, Z1
Firouzi, M1
Arshi, AR1
Kuznetsov, AV1
Javadov, S1
Saks, V1
Margreiter, R1
Grimm, M1
Zhang, Z1
Jiao, Y1
Zhu, M1
Zhang, S1
Komen, J1
Wolbers, F1
Franke, HR1
Andersson, H1
Vermes, I1
van den Berg, A1
Sim, HM1
Lee, CY1
Ee, PL1
Go, ML1
Blokh, D1
Stambler, I1
Afrimzon, E2
Platkov, M1
Shafran, Y2
Korech, E1
Sandbank, J2
Zurgil, N2
Deutsch, M2
Banerjee, J1
Hanson, AJ1
Gadam, B1
Elegbede, AI1
Tobwala, S1
Ganguly, B1
Wagh, AV1
Muhonen, WW1
Law, B1
Shabb, JB1
Srivastava, DK1
Mallik, S1
Shishido, T1
Mieda, H1
Hwang, SY1
Nishimura, Y1
Tanaka, T1
Ogino, C1
Fukuda, H1
Kondo, A1
Pasquier, J1
Magal, P1
Boulangé-Lecomte, C1
Webb, G1
Le Foll, F1
Qin, G1
Li, Z1
Xia, R1
Li, F1
O'Neill, BE1
Goodwin, JT1
Khant, HA1
Chiu, W1
Li, KC1
Shieh, MJ1
Hsu, CY1
Huang, LY1
Chen, HY1
Huang, FH1
Lai, PS1
Goldenbogen, B1
Brodersen, N1
Gramatica, A1
Loew, M1
Liebscher, J1
Herrmann, A1
Egger, H1
Budde, B1
Arbuzova, A1
Srinivas, P1
Patra, CR1
Bhattacharya, S1
Kullberg, M1
Mann, K1
Anchordoquy, TJ1
Shingu, K1
Kruschinski, C1
Lührmann, A1
Grote, K1
Tschernig, T1
Von Hörsten, S1
Pabst, R1
Torchilin, VP1
Lukyanov, AN1
Gao, Z1
Papahadjopoulos-Sternberg, B1
DANIEL BEK, KV1
Wan, XS1
Zhou, Z1
Kennedy, AR1
Angelini, A1
Di Febbo, C1
Ciofani, G1
Di Nisio, M1
Baccante, G1
Di Ilio, C1
Cuccurullo, F1
Porreca, E1
Lin, PH2
Pan, WC1
Kang, YW1
Chen, YL1
Lin, CH2
Lee, MC1
Chou, YH1
Nakamura, J1
Viola-Rhenals, M1
Rieber, MS1
Rieber, M1
Cooray, HC1
Shahi, S1
Cahn, AP1
van Veen, HW1
Hladky, SB1
Barrand, MA1
Deutsch, A1
Pappo, I1
Stevens, N1
O'Connor, N1
Vishwasrao, H1
Samaroo, D1
Kandel, ER1
Akins, DL1
Drain, CM1
Turro, NJ1
Harner, RE1
Smith, JL1
Reynolds, DH1
Nishiki, M1
Amano, K1
Yamane, M1
Okumichi, T1
Ezaki, H1
van Marle, J2
Lindeman, J2
Ariens, AT1
Labruyère, W1
van Weeren-Kramer, J1
Meijer, CJ1
Persijn, JP1
van Niewenhuizen, W1
Baak, JP1
Boon, ME1
Jetha, N1
Godolphin, W1
O'Connell, MD1
Said, JW1
Uriel, J1
Failly-Crepin, C1
Villacampa, MJ1
Pineiro, A1
Geuskens, M1
Walker, RA1
Furnival, CM1
Chong, KC1
Watson, LR1
Visona, A1
Louis, CJ2
Sztynda, T1
Cheng, ZM1
Wyllie, RG2
McCarty, KS2
Hiatt, KB1
Budwit, DA1
Cox, EB1
Leight, G1
Reintgen, D1
Georgiade, G1
Siegler, HF1
Lonsdorfer, M1
Clements, NC1
Wittliff, JL1
Oxenhandler, RW1
McCune, R1
Subtelney, A1
Truelove, C1
Tyrer, HW1
Fisher, B1
Gunduz, N2
Zheng, S1
Saffer, EA1
Hanna, W1
Ryder, DE1
Mobbs, BG1
Penney, GC1
Hawkins, RA1
Barrows, GH1
Stroupe, SB1
Riehm, JD1
Nenci, I1
Dandliker, WB1
Meyers, CY1
Marchetti, E1
Marzola, A1
Fabris, G1
Price, EA1
Coombe, DR1
Murray, JC1
Hedley, DW1
Chow, S1
Goré, J1
Besson, P1
Hoinard, C1
Bougnoux, P1
Proano, E1
Perbeck, LG1
Chan, SD1
Dill, K1
Blomdahl, J1
Wada, HG1
Van Heusden, J1
de Jong, P1
Ramaekers, F1
Bruwiere, H1
Borgers, M1
Smets, G1
Gelmini, S1
Orlando, C1
Sestini, R1
Vona, G1
Pinzani, P1
Ruocco, L1
Pazzagli, M1
Stein, U1
Walther, W1
Wendt, J1
Schild, TA1
Lee, AH1
Tannock, IF1
Whitcombe, D1
Brownie, J1
Gillard, HL1
McKechnie, D1
Theaker, J1
Newton, CR1
Little, S1
Nordström, T1
Knekt, M1
Nordström, E1
Lindqvist, C1
Shammas, FV1
Van Eekelen, JA1
Wee, L1
Heikkilä, R1
Osland, A1
Kolárová, H1
Kotala, L1
Strnad, M1
Bancírová, M1
Lasovský, J1
Ambrozová, P1
Rust, WL1
Huff, JL1
Plopper, GE1
Hildenbrand, R1
Leitz, M1
Magdolen, V1
Luther, T1
Albrecht, S1
Graeff, H1
Stutte, HJ1
Bleyl, U1
Schmitt, M1
Chandel, NS1
Vander Heiden, MG1
Thompson, CB1
Schumacker, PT1
Zeisig, R1
Müller, K1
Maurer, N1
Arndt, D1
Fahr, A1
Laakkonen, P1
Porkka, K1
Hoffman, JA1
Ruoslahti, E1
Lee, SH2
Loewenstein, WR1
Zhang, RD1
Price, JE1
Fujimaki, T1
Bucana, CD1
Fidler, IJ1
Krogerus, L1
Andersson, LC1
Yamaguchi, Y1
Toge, T1
Baba, N1
Kuninobu, H1
Kegoya, Y1
Takayama, T1
Hattori, T1
Remmele, W1
Hildebrand, U1
Hienz, HA1
Klein, PJ1
Vierbuchen, M1
Behnken, LJ1
Heicke, B1
Scheidt, E1
Nagy, JA1
Herzberg, KT1
Masse, EM1
Zientara, GP1
Dvorak, HF1
Daxenbichler, G1
Dürken, M1
Marth, C1
Böck, G1
Dapunt, O1
Tamaki, K1
Hino, H1
Ohara, K1
Furue, M1
De Potter, CR1
Eechaute, W1
Roels, H1
Leusen, I1
Berthois, Y1
Pourreau-Schneider, N1
Gandilhon, P1
Mittre, H1
Tubiana, N1
Martin, PM1
Avner, B1
Avner, BP1
Gaydos, B1
Liao, SK1
Thurman, GB1
Oldham, RK1
Dansey, R1
Murray, J1
Ninin, D1
Bezwoda, WR1
Ashcroft, RG1
Pertschuk, LP1
Eisenberg, KB1
Carter, AC1
Feldman, JG1
Benz, C1
Wiznitzer, I1
Archer, FL1
Kao, VC1
Waghe, M1
Kumar, S1
Steward, JK1
Myers, MB1
Brock, D1
Cohn, I1
Karel, I1
Peleska, M1
Nagel, GA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase II Study of Eribulin in Brain Metastases From HER2-negative Breast Cancer Pre-treated With Anthracyclines and Taxanes[NCT03637868]Phase 20 participants (Actual)Interventional2019-02-26Withdrawn (stopped due to no enrollment)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for erythrosine and Breast Neoplasms

ArticleYear
    Emergency and critical care medicine, 2022, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm

2022
Junctional intercellular communication and the control of growth.
    Biochimica et biophysica acta, 1979, Feb-04, Volume: 560, Issue:1

    Topics: Animals; Breast Neoplasms; Calcium; Carcinoma, Hepatocellular; Cell Communication; Cell Count; Cell

1979

Trials

1 trial available for erythrosine and Breast Neoplasms

ArticleYear
    Emergency and critical care medicine, 2022, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasm

2022

Other Studies

98 other studies available for erythrosine and Breast Neoplasms

ArticleYear
Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
    Journal of fluorescence, 2022, Volume: 32, Issue:2

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Fluoresceins; Fluorescent Dyes; High-Thro

2022
Confocal microscopy analysis reveals that only a small proportion of extracellular vesicles are successfully labelled with commonly utilised staining methods.
    Scientific reports, 2022, 01-07, Volume: 12, Issue:1

    Topics: Breast Neoplasms; Dextrans; Extracellular Vesicles; Female; Fluoresceins; Fluorescent Dyes; HeLa Cel

2022
Comparison of Three Low-Molecular-Weight Fluorescent Probes for Measuring Free Zinc Levels in Cultured Mammary Cells.
    Nutrients, 2023, Apr-13, Volume: 15, Issue:8

    Topics: Breast Neoplasms; Cells, Cultured; Chelating Agents; Female; Fluoresceins; Fluorescent Dyes; Humans;

2023
Ultrasound-triggered herceptin liposomes for breast cancer therapy.
    Scientific reports, 2021, 04-06, Volume: 11, Issue:1

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug

2021
Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.
    Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup2

    Topics: Biological Transport; Breast Neoplasms; Doxorubicin; Drug Liberation; Estrogens; Estrone; Fluorescei

2018
Enhanced In Vitro Biocompatibility and Water Dispersibility of Magnetite and Cobalt Ferrite Nanoparticles Employed as ROS Formation Enhancer in Radiation Cancer Therapy.
    Small (Weinheim an der Bergstrasse, Germany), 2018, Volume: 14, Issue:21

    Topics: Biocompatible Materials; Breast Neoplasms; Cell Survival; Cobalt; Dynamic Light Scattering; Female;

2018
Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells.
    Breast cancer research and treatment, 2018, Volume: 172, Issue:2

    Topics: Antioxidants; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin;

2018
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.
    Anticancer research, 2019, Volume: 39, Issue:2

    Topics: Animals; Antigens, CD1d; Breast Neoplasms; Cell Line, Tumor; Female; Fluoresceins; Glycolipids; Huma

2019
Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.
    Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluoresce

2019
Multifunctional gold coated thermo-sensitive liposomes for multimodal imaging and photo-thermal therapy of breast cancer cells.
    Nanoscale, 2014, Jan-21, Volume: 6, Issue:2

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Contrast Media; Female; Fluoresceins; Gold; Human

2014
Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment.
    Molecular pharmaceutics, 2014, Mar-03, Volume: 11, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Membrane Permeability; Cell Proliferation;

2014
Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy.
    Nature communications, 2014, Nov-17, Volume: 5

    Topics: Animals; Apoptosis; Breast Neoplasms; Carrier Proteins; DNA-Binding Proteins; E2F1 Transcription Fac

2014
Dual in vivo photoacoustic and fluorescence imaging of HER2 expression in breast tumors for diagnosis, margin assessment, and surgical guidance.
    Molecular imaging, 2014, Volume: 13

    Topics: Animals; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Contrast Media; Fema

2014
Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenografts.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Drug Liberation; Fe

2015
Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Jul-10, Volume: 209

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Liberation; Fema

2015
Nanoshell-mediated targeted photothermal therapy of HER2 human breast cancer cells using pulsed and continuous wave lasers: an in vitro study.
    Lasers in medical science, 2015, Volume: 30, Issue:7

    Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Female; Fluoresceins; Fluo

2015
Synchronism in mitochondrial ROS flashes, membrane depolarization and calcium sparks in human carcinoma cells.
    Biochimica et biophysica acta. Bioenergetics, 2017, Volume: 1858, Issue:6

    Topics: Adenocarcinoma; Antioxidants; Breast Neoplasms; Calcium Signaling; Cell Line, Tumor; Colonic Neoplas

2017
Nuclear-Shell Biopolymers Initiated by Telomere Elongation for Individual Cancer Cell Imaging and Drug Delivery.
    Analytical chemistry, 2017, 04-04, Volume: 89, Issue:7

    Topics: Biopolymers; Breast Neoplasms; Cell Survival; Cells, Cultured; DNA, Neoplasm; Drug Delivery Systems;

2017
Viability analysis and apoptosis induction of breast cancer cells in a microfluidic device: effect of cytostatic drugs.
    Biomedical microdevices, 2008, Volume: 10, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Biological Assay; Breast Neoplasms; Cell Line, Tumor; Cell Surviva

2008
Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein).
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2008, Nov-15, Volume: 35, Issue:4

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette

2008
Comparative analysis of cell parameter groups for breast cancer detection.
    Computer methods and programs in biomedicine, 2009, Volume: 94, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case-Control Studies; Computational Biology; Compu

2009
Release of liposomal contents by cell-secreted matrix metalloproteinase-9.
    Bioconjugate chemistry, 2009, Volume: 20, Issue:7

    Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Female; Fluoresceins; Huma

2009
Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells.
    Bioorganic & medicinal chemistry letters, 2010, Oct-01, Volume: 20, Issue:19

    Topics: Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Female; Fluoresceins; Hepatitis B Antigens; Human

2010
Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model.
    Biology direct, 2011, Jan-26, Volume: 6

    Topics: Algorithms; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Communic

2011
Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery.
    Nanotechnology, 2011, Apr-15, Volume: 22, Issue:15

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Aniline Compounds; Biological Availability; Breast Neoplasms; Ce

2011
Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.
    Journal of controlled release : official journal of the Controlled Release Society, 2011, Jun-30, Volume: 152, Issue:3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Nu

2011
Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake.
    Langmuir : the ACS journal of surfaces and colloids, 2011, Sep-06, Volume: 27, Issue:17

    Topics: Biotin; Breast Neoplasms; Cell Line, Tumor; Disulfides; Doxorubicin; Drug Delivery Systems; Female;

2011
Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles.
    International journal of nanomedicine, 2011, Volume: 6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation

2011
Targeting Her-2+ breast cancer cells with bleomycin immunoliposomes linked to LLO.
    Molecular pharmaceutics, 2012, Jul-02, Volume: 9, Issue:7

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bacterial Toxins;

2012
Intratracheal macrophage-activating lipopeptide-2 reduces metastasis in the rat lung.
    American journal of respiratory cell and molecular biology, 2003, Volume: 28, Issue:3

    Topics: Adenocarcinoma; Animals; Bacterial Proteins; Breast Neoplasms; Cell Line; Fluoresceins; Fluorescent

2003
Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.
    Proceedings of the National Academy of Sciences of the United States of America, 2003, May-13, Volume: 100, Issue:10

    Topics: Animals; Antibodies; Biological Transport; Breast Neoplasms; Drug Carriers; Drug Design; Female; Flu

2003
[ON THE PRACTICAL VALUE OF THE MACROLUMINESCENCE ANALYSIS IN CANCER SURGERY].
    Voprosy onkologii, 1964, Volume: 10

    Topics: Breast Neoplasms; Fluoresceins; Humans; Intestinal Neoplasms; Neoplasms; Stomach Neoplasms; Surgical

1964
Adaptation of the dichlorofluorescein assay for detection of radiation-induced oxidative stress in cultured cells.
    Radiation research, 2003, Volume: 160, Issue:6

    Topics: Breast Neoplasms; Cell Line, Tumor; Female; Fluoresceins; Fluorescence; Humans; Oxidation-Reduction;

2003
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy.
    Cancer biology & therapy, 2005, Volume: 4, Issue:3

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cel

2005
Effects of naphthalene quinonoids on the induction of oxidative DNA damage and cytotoxicity in calf thymus DNA and in human cultured cells.
    Chemical research in toxicology, 2005, Volume: 18, Issue:8

    Topics: Aldehydes; Animals; Breast Neoplasms; Cattle; Cell Line, Tumor; Cell Survival; Cells, Cultured; DNA;

2005
Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate.
    Biochemical pharmacology, 2006, Mar-14, Volume: 71, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chelating Agents; Copper;

2006
Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids.
    European journal of pharmacology, 2006, Feb-15, Volume: 531, Issue:1-3

    Topics: Adenosine Triphosphatases; Adrenal Cortex Hormones; Antibiotics, Antineoplastic; ATP Binding Cassett

2006
Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
    Chemico-biological interactions, 2006, Aug-25, Volume: 162, Issue:2

    Topics: Benzoflavones; Breast Neoplasms; Catalase; Cell Line, Tumor; Cell Survival; Chelating Agents; Cytoch

2006
Intracellular esterase activity in living cells may distinguish between metastatic and tumor-free lymph nodes.
    Clinical & experimental metastasis, 2008, Volume: 25, Issue:3

    Topics: Aged; Antigen-Presenting Cells; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intr

2008
Two color RNA intercalating probe for cell imaging applications.
    Journal of the American Chemical Society, 2008, Jun-11, Volume: 130, Issue:23

    Topics: Animals; Breast Neoplasms; Fluoresceins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; H

2008
Fluorescein fundus study of metastatic breast carcinoma. Following cryohypophysectomy.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1967, Volume: 78, Issue:3

    Topics: Adenocarcinoma; Adult; Breast Neoplasms; Cryosurgery; Eye Neoplasms; Female; Fluoresceins; Fundus Oc

1967
Estrogen receptors in human breast cancer detected by the fluorescent estradiol histochemical and dextran coated charcoal techniques.
    The Japanese journal of surgery, 1984, Volume: 14, Issue:6

    Topics: Breast Neoplasms; Charcoal; Dextrans; Double-Blind Method; Estradiol; Female; Fluorescein-5-isothioc

1984
Estrogen receptors in human breast cancer. I. Specificity of the histochemical localization of estrogen receptors using an estrogen-albumin FITC complex.
    Virchows Archiv. B, Cell pathology including molecular pathology, 1982, Volume: 40, Issue:1

    Topics: Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Estrogens; Fluorescein-5-isothio

1982
Estrogen receptors in human breast cancer. II. Correlation between the histochemical method and biochemical assay.
    Virchows Archiv. B, Cell pathology including molecular pathology, 1982, Volume: 40, Issue:1

    Topics: Adult; Aged; Animals; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Epithelium; Estradi

1982
Unable to obtain good correlation.
    American journal of clinical pathology, 1982, Volume: 77, Issue:6

    Topics: Breast Neoplasms; Female; Fluoresceins; Humans; Receptors, Estrogen; Staining and Labeling

1982
Estrogen receptors in carcinoma of the breast. A comparison of the dextran-coated charcoal, immunofluorescent, and immunoperoxidase technics.
    American journal of clinical pathology, 1983, Volume: 80, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Charcoal; Dextrans; Female; Fluorescein-5-isothiocyanate; Fluorescein

1983
Incorporation of alphafetoprotein by the MCF-7 human breast cancer cell line.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 1984, Volume: 5, Issue:1

    Topics: Albumins; alpha-Fetoproteins; Animals; Autoradiography; Breast Neoplasms; Cell Line; Chickens; Fluor

1984
The binding of fluorescent-labelled concanavalin A to human breast tissue--a marker of differentiation.
    The Journal of pathology, 1983, Volume: 140, Issue:3

    Topics: Breast; Breast Neoplasms; Concanavalin A; Female; Fixatives; Fluorescein-5-isothiocyanate; Fluoresce

1983
Fluorescent cytochemical oestrogen receptor assay: is it valid in breast cancer?
    The British journal of surgery, 1983, Volume: 70, Issue:8

    Topics: Adsorption; Adult; Aged; Breast Neoplasms; Charcoal; Estradiol; Female; Fluorescein-5-isothiocyanate

1983
Lectin-binding affinities of human breast tumors.
    Cancer, 1983, Oct-01, Volume: 52, Issue:7

    Topics: Breast; Breast Neoplasms; Female; Fibrocystic Breast Disease; Fluorescein-5-isothiocyanate; Fluoresc

1983
Clinical response to hormone therapy correlated with estrogen receptor analyses. Biochemical v histochemical methods.
    Archives of pathology & laboratory medicine, 1984, Volume: 108, Issue:1

    Topics: Antibodies; Breast Neoplasms; Estradiol; Estrogens; Female; Fluorescein-5-isothiocyanate; Fluorescei

1984
Use of high-performance liquid chromatography in the evaluation of the synthesis and binding of fluorescein linked steroids to estrogen receptors.
    Journal of chromatography, 1983, Aug-26, Volume: 266

    Topics: Animals; Breast Neoplasms; Cattle; Chromatography, High Pressure Liquid; Cytosol; Female; Fluorescei

1983
Flow cytometric determination of estrogen receptors in intact cells.
    Cancer research, 1984, Volume: 44, Issue:6

    Topics: Breast Neoplasms; Cell Line; Female; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Hydroco

1984
Fluorescein-concanavalin A conjugates distinguish between normal and malignant human cells: a preliminary report.
    Experientia, 1981, May-15, Volume: 37, Issue:5

    Topics: Breast Neoplasms; Concanavalin A; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent An

1981
Fluoresceinated estrone binding by human and mouse breast cancer cells.
    Cancer research, 1982, Volume: 42, Issue:2

    Topics: Adult; Aged; Animals; Binding, Competitive; Biopsy, Needle; Breast Neoplasms; Cell Nucleus; Cytoplas

1982
Cellular localization of estrogen binding sites in human breast cancer.
    American journal of clinical pathology, 1982, Volume: 77, Issue:4

    Topics: Breast Neoplasms; Female; Fluoresceins; Histocytochemistry; Humans; Microscopy, Fluorescence; Neopla

1982
Histochemical detection of oestrogen receptors: a progress report.
    British journal of cancer, 1982, Volume: 45, Issue:2

    Topics: Animals; Binding, Competitive; Breast Neoplasms; Estradiol; Female; Fluoresceins; Histocytochemistry

1982
Nuclear uptake of a 17 beta-estradiol-fluorescein derivative as a marker of estrogen dependence.
    American journal of clinical pathology, 1980, Volume: 73, Issue:3

    Topics: Adult; Animals; Breast; Breast Neoplasms; Endometrium; Estradiol; Female; Fluoresceins; Humans; Micr

1980
Estrogen receptor cytochemistry by fluorescent estrogen.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1980, Volume: 28, Issue:10

    Topics: Animals; Breast; Breast Neoplasms; Cell Line; Estrone; Fluoresceins; Fluorescent Dyes; Histocytochem

1980
A simple fluorometric assay for quantifying the adhesion of tumour cells to endothelial monolayers.
    Clinical & experimental metastasis, 1995, Volume: 13, Issue:3

    Topics: Adenocarcinoma; Breast Neoplasms; Cell Adhesion; Cell Adhesion Molecules; Cell Communication; Cells,

1995
Evaluation of methods for measuring cellular glutathione content using flow cytometry.
    Cytometry, 1994, Apr-01, Volume: 15, Issue:4

    Topics: Animals; Breast Neoplasms; Bridged Bicyclo Compounds; Buthionine Sulfoximine; Carcinoma; Carcinosarc

1994
Na(+)-H+ antiporter activity in relation to membrane fatty acid composition and cell proliferation.
    The American journal of physiology, 1994, Volume: 266, Issue:1 Pt 1

    Topics: Acids; Blood; Breast Neoplasms; Cell Division; Cell Membrane; Extracellular Space; Fatty Acids; Fluo

1994
Influence of the site of skin incision on the circulation in the nipple-areola complex after subcutaneous mastectomy in breast cancer.
    Scandinavian journal of plastic and reconstructive surgery and hand surgery, 1996, Volume: 30, Issue:3

    Topics: Adult; Aged; Breast; Breast Implants; Breast Neoplasms; Dermatologic Surgical Procedures; Female; Fl

1996
Nonisotopic quantitation of mRNA using a novel RNase protection assay: measurement of erbB-2 mRNA in tumor cell lines.
    Analytical biochemistry, 1996, Nov-15, Volume: 242, Issue:2

    Topics: Actins; Animals; Biotin; Breast Neoplasms; Chemistry Techniques, Analytical; CHO Cells; Cricetinae;

1996
Fluorescein-labeled tyramide strongly enhances the detection of low bromodeoxyuridine incorporation levels.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1997, Volume: 45, Issue:2

    Topics: Breast Neoplasms; Bromodeoxyuridine; Female; Fluorescein; Fluoresceins; Humans; Immunohistochemistry

1997
Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification.
    Clinical chemistry, 1997, Volume: 43, Issue:5

    Topics: Base Sequence; Breast Neoplasms; DNA-Directed DNA Polymerase; DNA, Neoplasm; Fluoresceins; Fluoresce

1997
In situ RT-PCR using fluorescence-labeled primers.
    BioTechniques, 1997, Volume: 23, Issue:2

    Topics: Breast Neoplasms; DNA Primers; Fluorescein; Fluoresceins; Fluorescent Dyes; Humans; In Situ Hybridiz

1997
Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells.
    Cancer research, 1998, May-01, Volume: 58, Issue:9

    Topics: Amiloride; Animals; Antiporters; Bicarbonates; Breast Neoplasms; Chloride-Bicarbonate Antiporters; C

1998
A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping.
    Clinical chemistry, 1998, Volume: 44, Issue:5

    Topics: Alleles; BRCA2 Protein; Breast Neoplasms; Cystic Fibrosis; DNA; DNA, Neoplasm; Factor V; Female; Flu

1998
A microplate-based fluorometric assay for monitoring human cancer cell attachment to cortical bone.
    Analytical biochemistry, 1999, Feb-01, Volume: 267, Issue:1

    Topics: Animals; Bone Matrix; Bone Neoplasms; Breast Neoplasms; Cattle; Cell Adhesion; Female; Fluoresceins;

1999
Sensitive and quantitative one-step polymerase chain reaction using capillary electrophoresis and fluorescence detection for measuring cytokeratin 19 expression.
    Scandinavian journal of clinical and laboratory investigation, 1999, Volume: 59, Issue:8

    Topics: Bone Marrow; Breast Neoplasms; DNA Primers; Electrophoresis, Capillary; Fluoresceins; Fluorescence;

1999
[Fluorescence methods for studying cell damage].
    Sbornik lekarsky, 1998, Volume: 99, Issue:4

    Topics: Breast Neoplasms; Cell Survival; Female; Fluoresceins; Fluorescent Dyes; Humans; Indoles; Isoindoles

1998
Screening assay for promigratory/antimigratory compounds.
    Analytical biochemistry, 2000, Apr-10, Volume: 280, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Drug Screening Assays, Antitumor; Fluoresceins; Fluorescent

2000
Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization.
    Histopathology, 2000, Volume: 36, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibody Specificity; Breast; Breast Neoplas

2000
Redox regulation of p53 during hypoxia.
    Oncogene, 2000, Aug-10, Volume: 19, Issue:34

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetylcysteine; Animals; Antioxidants; Breast Neop

2000
The composition-dependent presence of free (micellar) alkylphospholipid in liposomal formulations of octadecyl-1,1-dimethyl-piperidino-4-yl-phosphate affects its cytotoxic activity in vitro.
    The Journal of membrane biology, 2001, Jul-01, Volume: 182, Issue:1

    Topics: Breast Neoplasms; Cell Division; Cell Survival; Chemistry, Pharmaceutical; Cholesterol; Ethanolamine

2001
A tumor-homing peptide with a targeting specificity related to lymphatic vessels.
    Nature medicine, 2002, Volume: 8, Issue:7

    Topics: Animals; Breast Neoplasms; Cell Nucleus; Female; Fluoresceins; Humans; Lymphatic System; Male; Mice;

2002
Cytochemical study of estrogen receptor in human mammary cancer.
    American journal of clinical pathology, 1978, Volume: 70, Issue:2

    Topics: Breast Neoplasms; Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Estradiol; Estrogens; F

1978
Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice.
    The American journal of pathology, 1992, Volume: 141, Issue:5

    Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Cell Membrane; Cell Membrane Permea

1992
Different lectin-binding patterns in primary breast cancers and their metastases.
    Cancer, 1990, Oct-15, Volume: 66, Issue:8

    Topics: Breast Neoplasms; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Glycoconjugates; Hum

1990
The analysis of lymphocyte surface receptors recognized by wheat germ agglutinin for negative regulation of immune responses in cancer patients.
    The Japanese journal of surgery, 1990, Volume: 20, Issue:1

    Topics: Antigens, Surface; Breast Neoplasms; Esophageal Neoplasms; Flow Cytometry; Fluorescein-5-isothiocyan

1990
Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.
    Virchows Archiv. A, Pathological anatomy and histopathology, 1986, Volume: 409, Issue:2

    Topics: Antibodies, Monoclonal; Breast Neoplasms; Charcoal; Dextrans; Female; Fluorescein-5-isothiocyanate;

1986
Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice.
    Cancer research, 1989, Oct-01, Volume: 49, Issue:19

    Topics: Adenocarcinoma; Animals; Ascites; Biological Transport; Breast Neoplasms; Capillary Permeability; De

1989
Influence of steroids and retinoic acid on peanut-lectin binding of human breast cancer cells.
    Journal of steroid biochemistry, 1986, Volume: 24, Issue:1

    Topics: Breast Neoplasms; Cell Line; Dexamethasone; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Huma

1986
Lectin-binding sites in Paget's disease.
    The British journal of dermatology, 1985, Volume: 113, Issue:1

    Topics: Apocrine Glands; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Eccrine Glands;

1985
Comparative study between histochemical and biochemical estimation of estrogen receptors in tumors.
    Journal of receptor research, 1985, Volume: 5, Issue:4

    Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Centrifugation, Density Gradient; Cytosol

1985
Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems.
    Journal of steroid biochemistry, 1986, Volume: 25, Issue:6

    Topics: Binding Sites; Binding, Competitive; Breast Neoplasms; Cell Line; Cell Membrane; Estradiol; Estrogen

1986
Characterization of a method using viable human target cells as the solid phase in a cell concentration fluorescence immunoassay (CCFIA) for screening of monoclonal antibodies and hybridoma supernatants.
    Journal of immunological methods, 1988, Oct-04, Volume: 113, Issue:1

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line; Cell Survival; Cell-Fr

1988
Lectin binding in human breast cancer: clinical and pathologic correlations with fluorescein-conjugated peanut, wheat germ and concanavalin A binding.
    Oncology, 1988, Volume: 45, Issue:4

    Topics: Breast Neoplasms; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Lectins; Middle Aged;

1988
Measurement of ligand binding, E-BSA-FITC.
    Cytometry, 1986, Volume: 7, Issue:3

    Topics: Breast Neoplasms; Estradiol; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Serum Albumin, Bovi

1986
Heterogeneity of estrogen binding sites in breast cancer: morphologic demonstration and relationship to endocrine response.
    Breast cancer research and treatment, 1985, Volume: 5, Issue:2

    Topics: Binding Sites; Breast Neoplasms; Cell Nucleus; Cytoplasm; Estradiol; Female; Fluorescein; Fluorescei

1985
The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
    Cytometry, 1985, Volume: 6, Issue:6

    Topics: Antibodies, Monoclonal; Autoradiography; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Fluorescei

1985
Flow cytometric analysis of fluorescein-conjugated estradiol (E-BSA-FITC) binding in breast cancer suspensions.
    Cytometry, 1985, Volume: 6, Issue:3

    Topics: Binding, Competitive; Breast Neoplasms; Cell Line; Diethylstilbestrol; Estradiol; Female; Flow Cytom

1985
Immunohistochemical identification of actomyosin in myoepithelium of human tissues.
    Laboratory investigation; a journal of technical methods and pathology, 1968, Volume: 18, Issue:6

    Topics: Animals; Breast; Breast Neoplasms; Cytoplasm; Epithelial Cells; Epithelium; Female; Fluoresceins; Fl

1968
The lack of effect of mouse epidermal growth factor (EGF) and its anti-serum on human tissues.
    European journal of cancer, 1973, Volume: 9, Issue:8

    Topics: Adenocarcinoma; Animals; Breast; Breast Neoplasms; Culture Techniques; Female; Fluoresceins; Growth

1973
Prevention of skin slough after radical mastectomy by the use of a vital dye to delineate devascularized skin.
    Annals of surgery, 1971, Volume: 173, Issue:6

    Topics: Breast Neoplasms; Fluoresceins; Humans; Mastectomy; Necrosis; Postoperative Complications; Skin; Ski

1971
Fluorescence angiography in intraocular tumours.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1972, Volume: 164, Issue:3

    Topics: Adenocarcinoma; Breast Neoplasms; Bronchial Neoplasms; Choroid Neoplasms; Diagnosis, Differential; E

1972
[Immunosuppression: a paraneoplastic syndrome].
    Schweizerische medizinische Wochenschrift, 1971, Apr-03, Volume: 101, Issue:13

    Topics: Adenocarcinoma; Adult; Breast Neoplasms; Bronchial Neoplasms; Culture Techniques; Cyclophosphamide;

1971